Oliver Gross

Oliver Gross

Auto-generated profile, based on publicly available information

Oliver Gross

Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, Switzerland

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Journal of Urology
Verified
Journal Article
Open access
MKMarko Kozomara
Marko Kozomara
VBVeronika Birkhäuser
Veronika Birkhäuser
CACollene E Anderson
Collene E Anderson
MBMirjam Bywater
Mirjam Bywater
OGOliver Gross
Oliver Gross
Thomas M. KesslerThomas M. Kessler
Thomas M. Kessler
Purpose:We aimed to provide a real-world description of neurogenic lower urinary tract dysfunction within the first year after spinal cord injury with a focus on unfavorable urodynamic para...

2 August 2023 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
VNVera Neumeier
Vera Neumeier
FSFabian Peter Stangl
Fabian Peter Stangl
JBJoëlle Borer
Joëlle Borer
CACollene E Anderson
Collene E Anderson
VBVeronika Birkhäuser
Veronika Birkhäuser
LLLorenz Leitner
Lorenz Leitner
Background: Patients with neurogenic lower urinary tract dysfunction (NLUTD) often rely on some type of catheterization for bladder emptying. Intermittent catheterization (IC) is considered the gold standard and is preferred over continuous catheterization, since it is considered to cause fewer urinary tract infections (UTIs) than indwelling catheterization. The main objective of our study was to describe UTI prevalence (at visit) and incidence (within the last 12 months) and urine culture characteristics between patients using an indwelling catheter versus (vs) those performing IC. Methods: In this cross-sectional study, we prospectively evaluated from 02/2020 to 01/2021 patients with NLUTD undergoing urine cultures for prophylactic reasons or due to UTI symptoms. At visit, all patients underwent a standardized interview on current UTI symptoms as well as UTI history and antibiotic consumption within the past year. Patients using an indwelling catheter (n = 206) or IC (n = 299) were included in the analysis. The main outcome was between-group differences regarding UTI characteristics. Results: Patients using an indwelling catheter were older (indwelling catheter vs IC: median 66 (Q1-Q3: 55—77) vs 55 (42—67) years of age) and showed a higher Charlson comorbidity index (indwelling catheter vs IC: median 4 (Q1-Q3: 2–6) vs 2 (1–4) (both p < 0·001). A total of 40 patients from both groups were diagnosed with a UTI at visit (indwelling catheters vs IC: 8% (16/206) vs 8% (24/299); p = 0·782), and the number of UTIs within the past 12 months was not significantly different between groups. Overall, Escherichia coli (21%), Enterococcus faecalis (17%), and Klebsiella spp. (12%) were the most frequently detected bacteria. Conclusions: In this cohort of patients with NLUTD, we did not find relevant differences in UTI frequency between groups. These results suggest that UTI-related concerns should not be given undue emphasis when counseling patients for catheter-related bladder emptying methods.

28 October 2022 in BJU International
Verified
Journal Article
Open access
CACollene E Anderson
Collene E Anderson
MKMarko Kozomara
Marko Kozomara
VBVeronika Birkhäuser
Veronika Birkhäuser
MBMirjam Bywater
Mirjam Bywater
OGOliver Gross
Oliver Gross
Thomas M. KesslerThomas M. Kessler
Thomas M. Kessler
Objectives: To describe the temporal development of and risk factors for the occurrence of unfavourable urodynamic parameters during the first year after spinal cord injury (SCI). Patients and Methods: This population‐based longitudinal study used data from 97 adult patients with a single‐event traumatic or ischaemic SCI who underwent video‐urodynamic investigation (UDI) at a university SCI centre. The first occurrences of unfavourable urodynamic parameters (detrusor overactivity combined with detrusor sphincter dyssynergia [DO‐DSD], maximum storage detrusor pressure ≥40 cmH 2 O, bladder compliance <20 mL/cmH 2 O, vesico‐ureteric reflux [VUR] and any unfavourable parameter [composite outcome]) were evaluated using time‐to‐event analysis. Results: The majority of the population (87/97 [90%]) had at least one unfavourable urodynamic parameter. Most unfavourable urodynamic parameters were initially identified during the 1‐ or 3‐month UDI, including 92% of the DO‐DSD (78/85), 82% of the maximum storage pressure ≥40 cmH 2 O (31/38), and 100% of the VUR (seven of seven) observations. No low bladder compliance was observed. The risk of DO‐DSD was elevated in patients with thoracic SCI compared to those with lumbar SCI (adjusted hazard ratio [aHR] 2.38, 95% confidence interval [CI] 1.16–4.89). Risk of maximum storage detrusor pressure ≥40 cmH 2 O was higher in males than females (aHR 8.33, 95% CI 2.51–27.66), in patients with a cervical SCI compared to those with lumbar SCI (aHR 14.89, 95% CI 3.28–67.55), and in patients with AIS Grade B or C compared to AIS Grade D SCI (aHR 6.17, 95% CI 1.78–21.39). No risk factors were identified for the composite outcome of any unfavourable urodynamic parameter. Conclusions: The first UDI should take place within 3 months after SCI as to facilitate early diagnosis of unfavourable urodynamic parameters and timely treatment. Neuro‐urological guidelines and individualised management strategies for patients with SCI may be strengthened by considering sex and SCI characteristics in the scheduling of UDIs.

17 June 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
VBVeronika Birkhäuser
Veronika Birkhäuser
CACollene E Anderson
Collene E Anderson
MKMarko Kozomara
Marko Kozomara
MBMirjam Bywater
Mirjam Bywater
OGOliver Gross
Oliver Gross
Thomas M. KesslerThomas M. Kessler
Thomas M. Kessler
We used clinical parameters to develop a prediction model for the occurrence of urodynamic risk factors for upper urinary tract (UUT) damage during the first year after acute spinal cord injury (SCI). A total of 97 patients underwent urodynamic investigation at 1, 3, 6, and 12 months after acute SCI, within the framework of a population-based longitudinal study at a single university SCI center. Candidate predictors included demographic characteristics and neurological and functional statuses 1 month after SCI. Outcomes included urodynamic risk factors for UUT damage: detrusor overactivity combined with detrusor sphincter dyssynergia, maximum storage detrusor pressure (pDetmax) ≥ 40 cmH2O, bladder compliance < 20 mL/cmH2O, and vesicoureteral reflux. Multivariable logistic regression was used for the prediction model development and internal validation, using the area under the receiver operating curve (aROC) to assess model discrimination. Two models showed fair discrimination for pDetmax ≥ 40 cmH2O: (i) upper extremity motor score and sex, aROC 0.79 (95% CI: 0.69–0.89), C-statistic 0.78 (95% CI: 0.69–0.87), and (ii) neurological level, American Spinal Injury Association Impairment Scale grade, and sex, aROC 0.78 (95% CI: 0.68–0.89), C-statistic 0.76 (95% CI: 0.68–0.85). We identified two models that provided fair predictive values for urodynamic risk factors of UUT damage during the first year after SCI. Pending external validation, these models may be useful for clinical trial planning, although less so for individual-level patient management. Therefore, urodynamics remains essential for reliably identifying patients at risk of UUT damage.

13 June 2023 in BJU International
Verified
Journal Article
Open access
SSStephanie A Stalder
Stephanie A Stalder
OGOliver Gross
Oliver Gross
CACollene E Anderson
Collene E Anderson
LBLucas M. Bachmann
Lucas M. Bachmann
SBSarah Baumann
Sarah Baumann
Thomas M. KesslerThomas M. Kessler
Thomas M. Kessler
Objective: To present the protocol for a randomized controlled trial (RCT) evaluating the efficacy and safety of transcutaneous tibial nerve stimulation (TTNS) for refractory neurogenic lower urinary tract dysfunction (NLUTD). Study Design and Results: bTUNED (bladder and TranscUtaneous tibial Nerve stimulation for nEurogenic lower urinary tract Dysfunction) is an international multicentre, sham‐controlled, double‐blind RCT investigating the efficacy and safety of TTNS. The primary outcome is success of TTNS, defined as improvements in key bladder diary variables at study end compared to baseline values. The focus of the treatment is defined by the Self‐Assessment Goal Achievement (SAGA) questionnaire. Secondary outcomes are the effect of TTNS on urodynamic, neurophysiological, and bowel function outcome measures, as well as the safety of TTNS. Conclusions: A total of 240 patients with refractory NLUTD will be included and randomized 1:1 into the verum or sham TTNS group from March 2020 until August 2026. TTNS will be performed twice a week for 30 min during 6 weeks. The patients will attend baseline assessments, 12 treatment visits and follow‐up assessments at the study end.

18 September 2025 in BJU International
Verified
Journal Article
Open access
VBVeronika Birkhäuser
Veronika Birkhäuser
CACollene E Anderson
Collene E Anderson
MKMarko Kozomara
Marko Kozomara
MBMartin WG Brinkhof
Martin WG Brinkhof
OGOliver Gross
Oliver Gross
Thomas M. KesslerThomas M. Kessler
Thomas M. Kessler
Objective: To evaluate sex differences in maximum storage detrusor pressure (Pdet max storage), focusing on Pdet max storage ≥40 cmH 2 O, an established risk factor for upper urinary tract damage, within the first year after spinal cord injury (SCI). Patients and Methods: A cohort of patients with neurogenic lower urinary tract dysfunction due to acute traumatic or ischaemic SCI, managed according to the European Association of Urology Guidelines on Neuro‐Urology, prospectively underwent urodynamic investigations at 1, 3, 6 and 12 months after SCI at a university SCI centre. Pearson's chi‐squared tests and multivariable regression analyses were used to compare outcomes between females and males. Results: Of 97 patients, 34% were female. Within the first year after SCI, 9% of females presented with a Pdet max storage ≥40 cmH 2 O, compared to 55% of males ( P < 0.001). Females had lower Pdet max storage than males, with a grand mean (standard deviation [SD]) of 13 (9) vs 30 (20) cmH 2 O (coefficient = 18 cmH 2 O, 95% confidence interval [CI] 13–24 cmH 2 O; P < 0.001). Females also had lower detrusor overactivity leak‐point pressure (DOLPP) than males, with a grand mean (SD) of 15 (4) vs 35 (21) cmH 2 O (coefficient = 20 cmH 2 O, 95% CI 11–29 cmH 2 O; P < 0.001). The cumulative incidence of antimuscarinic therapy and reported urinary incontinence was similar between sexes (female vs male: 55% vs 70%, P = 0.12; 53% vs 43%, P = 0.42, respectively). Conclusions: Females rarely reached a Pdet max storage ≥40 cmH 2 O during the first year after SCI and had lower Pdet max storage and DOLPP than males. However, the prevalence of urinary incontinence was similar between the sexes, suggesting the need for a more sex‐tailored approach to patient management.